KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Current Taxes (2023 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Current Taxes for 3 consecutive years, with $313000.0 as the latest value for Q4 2025.

  • Quarterly Current Taxes fell 94.5% to $313000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $313000.0 through Dec 2025, down 94.5% year-over-year, with the annual reading at $313000.0 for FY2025, 94.5% down from the prior year.
  • Current Taxes for Q4 2025 was $313000.0 at Xenon Pharmaceuticals, up from $231000.0 in the prior quarter.
  • The five-year high for Current Taxes was $6.6 million in Q1 2025, with the low at $231000.0 in Q3 2025.
  • Average Current Taxes over 3 years is $2.5 million, with a median of $1.1 million recorded in 2023.
  • The sharpest move saw Current Taxes skyrocketed 1538.62% in 2024, then plummeted 94.5% in 2025.
  • Over 3 years, Current Taxes stood at $347000.0 in 2023, then surged by 1538.62% to $5.7 million in 2024, then tumbled by 94.5% to $313000.0 in 2025.
  • According to Business Quant data, Current Taxes over the past three periods came in at $313000.0, $231000.0, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.